Insights into Molecular and Cellular Mechanisms of NeuroCOVID
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cells of the Nervous System".
Deadline for manuscript submissions: closed (20 December 2023) | Viewed by 41301
Special Issue Editors
Interests: NeuroCOVID-19; SARS-CoV-2; post-COVID-19 syndrome; microRNA; RNA-induced silencing complex (RISC); RNA-binding protein; neurodegenerative disease; Alzheimer’s disease; small non-coding RNA; RNA metabolism; cellular and molecular neurobiology; translational biomedicine
Special Issues, Collections and Topics in MDPI journals
Interests: otolaryngology; speech and language pathology; audiology; head and neck surgery; hearing disorders; ENT; rhinology; sleep disorders and sleep medicine; sinusitis; anosmia; neuroCOVID; post-COVID-19
Special Issues, Collections and Topics in MDPI journals
Interests: gut-brain axis; pediatric rare disease; neurophins: BDNF; NGF; anitoxidant and antiinflammatory natural compounds: probiotics and Polyphenols
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Post-COVID-19 syndrome (PCS), or long-haul COVID, is defined by the persistence or recurrence of symptoms after initial SARS-CoV-2 infection. This condition continues for more than 12 weeks and cannot be attributed to other clinical situations. PCS patients are affected by neurological, cardiac, and respiratory symptoms like dyspnea, fatigue, loss of olfactory and taste function with anosmia and dysgeusia, neurocognitive symptoms defined as “brain fog”, sleep disturbance, weakness, and chronic pain reducing physical and mental quality of life. In particular, the brain involvement, and more generally the central and peripheral nervous systems, as potential target organs of SARS-CoV-2 that can be affected during and after infection has been defined as neuroCOVID. Numerous studies have documented neurological and neuropsychological complications, and the effects of COVID-19 on the nervous system are becoming better defined. Now, it is evident that these disorders can also affect young people (30–50 years of age) who 1) had never previously experienced these symptoms, 2) had developed even very mild forms of COVID, or 3) had not experienced breathing problems. The aim of this Special Issue entitled “Insights into Molecular and Cellular Mechanisms of NeuroCOVID” is to explore integrated models of translational biomedical research starting from long-lasting post-infective neurobiological modifications, exploring common molecular and cellular determinants of the neurosensorial and neurological clinical manifestation of this neuroCOVID wave. Original research and review articles from this Special Issue will provide recent molecular and cellular neurobiological findings as well as translational biomedicine studies that highlight working hypotheses, route(s) for SARS-CoV-2 entry to the CNS, relative consequences, post-infective neuropathology, potential relationships with neurodegenerative diseases, and therapy. Researchers and clinicians are allied in unraveling the molecular and cellular pathogenetic mechanisms and the clinical development of this unexpected SARS-CoV-2 infectious evolution, mapping the geography of neuroCOVID.
Dr. Christian Barbato
Prof. Dr. Antonio Minni
Dr. Carla Petrella
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- SARS-CoV-2
- neuroCOVID
- post-COVID-19 syndrome
- neurodegenerative disease
- brain fog
- anosmia
- dysgeusia
- neurocognitive disease
- neurosensorial
- Alzheimer’s disease
- Parkinson’s disease
- non-coding RNA
- neurotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
